Hospira, Inc.
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
Other Names/Subsidiaries
- Javelin Pharmaceuticals, Inc.
- Mayne Pharma Limited
Latest on Hospira, Inc.
US suitability petitions may be seeing renewed interest from sponsors following a surge of filings after the introduction of goal dates in October and then a drop-off of submissions after that. Nimish
Cipla Limited rang in strong earnings in the first quarter of fiscal 2024, lifted by robust growth across its key markets of India, the US and South Africa. The US revenue bump up of 43% was particul
Cipla Limited rang in strong earnings in the first quarter of fiscal 2024, lifted by robust growth across its key markets of India, the US and South Africa. The US revenue bump up of 43% was particul
US Patent and Trademark Office officials sought to tamp down industry concerns about a notice it issued advising patent applicants to ensure that the information they submit to the USPTO is consistent